PATH: New Wave 5 Youth and Young Adult Data Files Released FDA's Center for Tobacco Products (CTP) and NIH's National Institute on Drug Abuse (NIDA) announce the release of new Wave 5 Biomarker Restricted-Use Files (BRUFs) for Youth and Young Adults (14-19 years old) from the Population Assessment of Tobacco and Health (PATH) Study collected December 2018 through November 2019, including: - Wave 5: Youth Urine Collection and NEQ Data
- Wave 5: Urine Biomarker Weights - Wave 4 Biomarker Core - Single-Wave Urine Weights
- Wave 5: Urine Panel - Wave 4 Biomarker Core - Enzymatic Urinary Creatinine (CREAU)
- Wave 5: Urine Panel - Wave 4 Biomarker Core - Metals (Metals)
- Wave 5: Urine Panel - Wave 4 Biomarker Core - Urinary Nicotine Metabolites (Cotinine and Hydroxycotinine) (UNICM)
These Wave 5 biomarker data were collected from participants in the Wave 4 Biomarker Core, a cohort who were youth (12 to 17 years old) in Wave 4 and youth and young adults (14 to 19 years old) in Wave 5. This cohort provided biospecimens at both Waves 4 and 5. Updated versions of the previously released Restricted-Use Master Linkage Files are also now available. Questions about the collection, content, weighting, documentation, or structure of PATH Study data (this excludes questions on statistical analysis or analytic guidance) may be submitted to PATHDataUserQuestions@Westat.com. | 
No comments:
Post a Comment